BenzePrO Short Contact Foam Prescribing Information

Active ingredients

Benzoyl Peroxide 9.8%

Purpose

Acne Treatment

Indications and Usage for BenzePrO Short Contact Foam

Indicated for the topical treatment of mild to moderate acne vulgaris

Warnings

For external use only

Related/similar drugs

doxycycline, clindamycin topical, erythromycin topical, tetracycline, Tazorac

BenzePrO Short Contact Foam Dosage and Administration

See package insert for full prescribing information

Prime can before initial use: See package insert Before Each Use: Shake vigorously

During Use: Holding can upright, dispense into palm of hand and apply to affected area as directed by physician.

• If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.

Other Information

• Store at room temperature 15°-25° C (59°-77° F)
  
• Protect from freezing
  
• Store upright

Inactive ingredients

BHT, C12-15 alkyl benzoate, cetostearyl alcohol, citric acid, dimethicone, disodium EDTA, emulsifying wax, glycerin, methylparaben, povidone, propylene glycol, propylparaben, purified water, sodium citrate, steareth-10, stearic acid, trolamine. Also contains: Propellant HFA-134A (1, 1, 1, 2-tetrafluoroethane).

Questions? 866-696-8525

Manufactured for:
PruGen, Inc.
Pharmaceuticals
18899 Notrh Tompson Peak Parkway
Scottsdale, AZ 85255 REV 1.2

PRINCIPAL DISPLAY PANEL - 100 g Canister Box

NDC 42546-015-10
Rx only

BenzePrO®

Short Contact Foam
benzoyl peroxide

9.8%

For topical treatment
of mild to moderate
acne vulgaris

Net Weight 100 g

Will not dispense entire contents.
Container is overfilled to guarantee
dispensing at least the listed amount.

PRUGEN™
PHARMACEUTICALS